Robinhood Markets, Inc. sold $294K of RVI

Robinhood Markets, Inc. sold 11,578 shares of Robinhood Ventures Fund I (RVI) at an average of $25.39 ($25.16–$25.55, $0.29M total) across 2 trades over 2026-10-15 to 2026-10-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Robinhood Markets, Inc.
Published Oct 19, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$RVI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale is modest in size, suggesting limited immediate price impact, but it adds to the cumulative insider activity profile.

02

Market read

Provides a fresh insider transaction detail for HOOD, useful for short‑term traders monitoring insider activity.

03

What to watch

Potential upcoming product launches or earnings could offset any short‑term pressure from the sale.

Relevance 3/10Novelty 3/10Timing: post‑market filing

Background

Form 4 disclosures provide the first public record of insider transactions, offering transparency to investors.

Market effects

Minimal impact on the broader fintech sector; similar insider sales are routine.

No significant regional effect; the filing is U.S.‑focused.

Limited global relevance; only investors in HOOD may adjust positions.

Counterpoint

The sale could be a routine liquidity move unrelated to fundamentals, so price may remain unchanged.

Key entities

  • Robinhood Markets, Inc.

    U.S. listed fintech platform (ticker HOOD).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).